Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HRMY
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,123 Reduced 100.0% |
$44,920
$40.0 p/Share
|
Jan 21
2025 |
|
SLB
|
Khaled Al Mogharbel
EVP, Geographies |
SELL
Open market or private sale
|
Direct | 123,097 Reduced 40.0% |
$5,423,653
$44.06 p/Share
|
Jan 21
2025 |
|
SLB
|
Vijay Kasibhatla
Director, M&A |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 33.51% |
$1,098,500
$43.94 p/Share
|
Jan 21
2025 |
|
SLB
|
Dianne B. Ralston
Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct | 43,161 Reduced 15.52% |
$1,897,357
$43.96 p/Share
|
Jan 21
2025 |
|
SLB
|
Howard Guild
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 13,568 Reduced 35.43% |
$595,228
$43.87 p/Share
|
Jan 21
2025 |
|
SLB
|
Ugo Prechner
VP Controller |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 38.38% |
$309,400
$44.2 p/Share
|
Jan 21
2025 |
|
SLB
|
Stephane Biguet
EVP & CFO |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 17.89% |
$1,974,150
$43.87 p/Share
|
Jan 21
2025 |
|
GWRE
|
Michael George Rosenbaum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 0.5% |
$251,874
$179.91 p/Share
|
Jan 21
2025 |
|
TYRA
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect | 3,993 Reduced 0.0% |
$65,325
$16.36 p/Share
|
Jan 21
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.93% |
$941,175
$125.49 p/Share
|
Jan 21
2025 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.06% |
$286,000
$11.44 p/Share
|
Jan 21
2025 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 114,583 Reduced 0.24% |
$9,360,285
$81.69 p/Share
|
Jan 21
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 0.0% |
$2,331,350
$66.61 p/Share
|
Jan 21
2025 |
|
NET
|
Thomas J Seifert
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 31,136 Reduced 10.96% |
$3,739,433
$120.1 p/Share
|
Jan 21
2025 |
|
ABEO
|
Mark Alvino
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 5.53% |
$20,400
$5.1 p/Share
|
Jan 21
2025 |
|
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.69% |
$91,840
$45.92 p/Share
|
Jan 21
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 265,580 Reduced 0.0% |
$605,522
$2.28 p/Share
|
Jan 17
2025 |
|
RH
|
Edward T Lee |
SELL
Open market or private sale
|
Direct | 600 Reduced 100.0% |
$268,038
$446.73 p/Share
|
Jan 17
2025 |
|
RH
|
Christina Hargarten
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 5,280 Reduced 91.6% |
$2,361,744
$447.3 p/Share
|
Jan 17
2025 |
|
PNRG
|
Clint Hurt
Director |
SELL
Open market or private sale
|
Direct | 1,107 Reduced 0.83% |
$236,997
$214.09 p/Share
|
Jan 17
2025 |
|
DKS
|
Julie Lodge Jarrett
EVP, Chf People & Purpose Ofcr |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 23.25% |
$1,140,350
$228.07 p/Share
|
Jan 17
2025 |
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.4% |
$40,110
$40.11 p/Share
|
Jan 17
2025 |
|
PLRX
|
Keith Lamont Cummings
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,148 Reduced 7.13% |
$225,657
$11.2 p/Share
|
Jan 17
2025 |
|
PLRX
|
Bernard Coulie
President and CEO |
SELL
Open market or private sale
|
Direct | 52,419 Reduced 10.85% |
$587,092
$11.2 p/Share
|
Jan 17
2025 |
|
PLRX
|
Eric Lefebvre
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 18,478 Reduced 8.67% |
$206,953
$11.2 p/Share
|
Jan 17
2025 |
|
PLRX
|
Hans Hull
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 15,936 Reduced 7.01% |
$178,483
$11.2 p/Share
|
Jan 17
2025 |
|
PLRX
|
Mike Ouimette
General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct | 13,270 Reduced 14.11% |
$148,624
$11.2 p/Share
|
Jan 17
2025 |
|
PLRX
|
Lily Cheung
Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct | 3,740 Reduced 13.22% |
$41,888
$11.2 p/Share
|
Jan 17
2025 |
|
IOT
|
John Bicket |
SELL
Open market or private sale
|
Indirect | 54,164 Reduced 0.0% |
$2,511,043
$46.36 p/Share
|
Jan 17
2025 |
|
IOT
|
Sanjit Biswas
CHIEF EXECUTVE OFFICER |
SELL
Open market or private sale
|
Indirect | 72,077 Reduced 0.0% |
$3,344,372
$46.4 p/Share
|
Jan 17
2025 |
|
FLL
|
Lewis A. Fanger
Sr. VP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 7,597 Reduced 2.9% |
$37,985
$5.0 p/Share
|
Jan 17
2025 |
|
DORM
|
Steven L Berman
Director |
SELL
Open market or private sale
|
Direct | 2,775 Reduced 0.34% |
$364,135
$131.22 p/Share
|
Jan 17
2025 |
|
IBTA
|
Richard I. Donahue
CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct | 776 Reduced 0.36% |
$58,269
$75.09 p/Share
|
Jan 17
2025 |
|
TRMB
|
Jennifer Allison
Corporate VP, General Counsel |
SELL
Open market or private sale
|
Direct | 3,571 Reduced 53.08% |
$266,932
$74.75 p/Share
|
Jan 17
2025 |
|
COIN
|
Frederick Ernest Ehrsam Iii
Director |
SELL
Open market or private sale
|
Indirect | 5,262 Reduced 0.0% |
$1,579,073
$300.09 p/Share
|
Jan 17
2025 |
|
LOVE
|
Albert Jack Krause
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 16.87% |
$789,900
$26.33 p/Share
|
Jan 17
2025 |
|
GTLB
|
Robin Schulman
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 9,251 Reduced 7.05% |
$601,315
$65.0 p/Share
|
Jan 17
2025 |
|
VITL
|
Joanne Bal
GC, SEC. AND HEAD OF IMPACT |
SELL
Open market or private sale
|
Direct | 28,246 Reduced 32.24% |
$1,273,894
$45.1 p/Share
|
Jan 17
2025 |
|
VITL
|
Kathryn Mc Keon
CMO and GM, Butter |
SELL
Open market or private sale
|
Direct | 12,300 Reduced 21.02% |
$541,815
$44.05 p/Share
|
Jan 17
2025 |
|
SMTC
|
Imran Sherazi
SVP and GM |
SELL
Open market or private sale
|
Direct | 1,338 Reduced 98.96% |
$100,350
$75.0 p/Share
|
Jan 17
2025 |
|
ISSC
|
Christopher Harborne
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$101,600
$10.16 p/Share
|
Jan 17
2025 |
|
APLD
|
Richard N Nottenburg
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 5.51% |
$177,000
$8.85 p/Share
|
Jan 17
2025 |
|
AREN
|
Christopher Petzel
Director |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 49.99% |
$30,750
$1.23 p/Share
|
Jan 17
2025 |
|
NAN
|
Bank Of America Corp |
SELL
Open market or private sale
|
Indirect | 1,611 Reduced 0.0% |
$18,107
$11.24 p/Share
|
Jan 17
2025 |
|
MDB
|
Dev Ittycheria
President & CEO |
SELL
Open market or private sale
|
Direct | 8,335 Reduced 3.69% |
$2,122,591
$254.66 p/Share
|
Jan 17
2025 |
|
PRTHW
|
Ranjana Ram
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 18,385 Reduced 2.58% |
$136,784
$7.44 p/Share
|
Jan 17
2025 |
|
PRTHW
|
John Vito Priore
Director |
SELL
Open market or private sale
|
Direct | 3,454,575 Reduced 39.4% |
$25,702,038
$7.44 p/Share
|
Jan 17
2025 |
|
PRTHW
|
Thomas Charles Priore
President, CEO and Chairman |
SELL
Open market or private sale
|
Direct | 294,167 Reduced 0.86% |
$2,188,602
$7.44 p/Share
|
Jan 17
2025 |
|
PNC
|
William S Demchak
CEO |
SELL
Open market or private sale
|
Direct | 1,242 Reduced 0.24% |
$245,916
$198.0 p/Share
|
Jan 17
2025 |
|
PNRG
|
Robert De Rothschild |
SELL
Open market or private sale
|
Indirect | 1,831 Reduced 0.0% |
$391,266
$213.69 p/Share
|
Jan 17
2025 |